System captures and harvests intact circulating tumour cells for analysis
News
AZ’s Tagrisso scores priority review from FDA
Agency will review drug for the treatment of early-stage EGFR-mutated lung cancer
Experts partner with UK government for COVID-19 human challenge trials
NHS, academia and private sector join forces to explore and establish trials
UCB acquires new campus to support UK operations
Following completion of acquisition, site will undergo refurbishment
AbbVie’s Venclexta granted full US approval in AML
FDA approved therapy for newly-diagnosed acute myeloid leukaemia patients
ABPI chief exec says no-deal Brexit is ‘not in the interest of patients’
Chief executive of trade body warns no-deal could affect medicines supply
Ten new medicines backed for EU approval
Dupixent, Forxiga and Opdivo were also recommended for therapeutic extensions
CQC assessment is a ‘wake-up call’ to government, says NHS Confed chief exec
Latest reports highlights need for improved access to mental health care
Sanofi’s Sarclisa bags NICE recommendation
Treatment is approved for relapsed/refractory multiple myeloma
Janssen’s psoriasis med Tremfya scores long-term safety and efficacy data
Treatment demonstrated positive outcomes for nearly five years
Astellas to acquire iota Biosciences following R&D partnership
Companies will develop ultra-small implantable medical devices
NIHR review identifies long-term effects of COVID-19
Review draws on experiences of patients and expert consensus
Roche signs deal with Dyno Therapeutics for gene therapy vectors
Dyno could receive up to $1.8bn in collaboration-associated payments
NICE recommends Novartis’ Mayzent on the heels of SMC approval
Drug is licensed for secondary progressive multiple sclerosis with active disease
EMA confirms eligibility for submission of Moderna’s COVID-19 vaccine
Primes company to submit vaccine candidate for rolling review
